glp 1 in spain obesity Every question answered, and not
Description
Y.XuX.YangA
Furthermore, GLP-1 decreases glucagon secretion from pancreatic cells and has also extrapancreatic influences as a direct suppressive effect on appetite centers and a slowing of gastric emptying increasing the feeling of satiety
While hyperkalaemia occurred more frequently with finerenone than with placebo, this was often mild or moderate and resulted in few drug discontinuations (2.3% vs 0.9%, respectively), despite study participants also being on maximum-tolerated RAS inhibitor therapy
Forti, E
Currently, there is no cure, though some medications slow progression in select patients
